What is Cognition Therapeutics, Inc. Common Stock's Market Cap?

Cognition Therapeutics, Inc. Common Stock's Market Cap is $96.0M, based on as-reported figures from SEC (XBRL) filings.

What is Cognition Therapeutics, Inc. Common Stock's Enterprise Value?

Cognition Therapeutics, Inc. Common Stock's Enterprise Value is $62.0M, based on as-reported figures from SEC (XBRL) filings.

What is Cognition Therapeutics, Inc. Common Stock's EV / EBITDA?

Cognition Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Cognition Therapeutics, Inc. Common Stock's Net Income (TTM)?

Cognition Therapeutics, Inc. Common Stock's Net Income (TTM) is -$16.8M, based on as-reported figures from SEC (XBRL) filings.

What is Cognition Therapeutics, Inc. Common Stock's EBITDA?

Cognition Therapeutics, Inc. Common Stock's EBITDA is -$36.6M, based on as-reported figures from SEC (XBRL) filings.

What is Cognition Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Cognition Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.18, based on as-reported figures from SEC (XBRL) filings.

What is Cognition Therapeutics, Inc. Common Stock's Net Debt?

Cognition Therapeutics, Inc. Common Stock's Net Debt is -$34.0M, based on as-reported figures from SEC (XBRL) filings.

Cognition Therapeutics, Inc. Common Stock (CGTX) Financial Statements

Cognition Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001V0GFB9

XNAS · usd

1.01▲ 0.02 (2.02%)

As of 2026-09-10

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.99

Day's Range0.99 – 1.03

52-Week Range0.55 – 2.60

Volume468.7K

Avg Volume477.9K

Share Statistics

Shares Outstanding

Employees14

ExchangeXNAS

Listed2021-10-08

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Cognition Therapeutics, Inc. Common Stock (CGTX)

What is Cognition Therapeutics, Inc. Common Stock's Market Cap?: Cognition Therapeutics, Inc. Common Stock's Market Cap is $96.0M, based on as-reported figures from SEC (XBRL) filings.
What is Cognition Therapeutics, Inc. Common Stock's Enterprise Value?: Cognition Therapeutics, Inc. Common Stock's Enterprise Value is $62.0M, based on as-reported figures from SEC (XBRL) filings.
What is Cognition Therapeutics, Inc. Common Stock's EV / EBITDA?: Cognition Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Cognition Therapeutics, Inc. Common Stock's Net Income (TTM)?: Cognition Therapeutics, Inc. Common Stock's Net Income (TTM) is -$16.8M, based on as-reported figures from SEC (XBRL) filings.
What is Cognition Therapeutics, Inc. Common Stock's EBITDA?: Cognition Therapeutics, Inc. Common Stock's EBITDA is -$36.6M, based on as-reported figures from SEC (XBRL) filings.
What is Cognition Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Cognition Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.18, based on as-reported figures from SEC (XBRL) filings.
What is Cognition Therapeutics, Inc. Common Stock's Net Debt?: Cognition Therapeutics, Inc. Common Stock's Net Debt is -$34.0M, based on as-reported figures from SEC (XBRL) filings.